Sunshine Lake Pharma Co Ltd (6887)

Currency in HKD
40.76
+1.16(+2.93%)
Closed·
6887 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
39.3440.76
52 wk Range
15.0151.70
Key Statistics
Bid/Ask
40.76 / 40.78
Prev. Close
40.76
Open
39.62
Day's Range
39.34-40.76
52 wk Range
15.01-51.7
Volume
280.85K
Average Volume (3m)
615.33K
1-Year Change
-17.0871%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6887 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 31, 2026
EPS / Forecast
-1.09 / --
Revenue / Forecast
1.08B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.52%
Dividend Yield
-
Industry Median 2.63%
Annualised payout
-
Paid annually
5-Years Growth
-
Growth Streak

6887 Income Statement

Compare 6887 to Peers and Sector

Metrics to compare
6887
Peers
Sector
Relationship
P/E Ratio
−70.5x−12.7x−0.4x
PEG Ratio
0.50−0.120.00
Price/Book
5.2x2.6x2.6x
Price / LTM Sales
5.1x7.9x3.0x
Upside (Analyst Target)
-53.4%57.5%
Fair Value Upside
Unlock−1.1%7.8%Unlock

Sunshine Lake Pharma Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology. It offers Kewei for the treatment of influenza; Dongweien and Dongyinghe for the treatment of hepatitis C. The company also engages in the import, export, wholesale, retail, and distribution of pharmaceutical products, intermediates, and active pharmaceutical ingredients; product quality inspection; research and development of biosimilar drugs and new biologic; research and production of generic drug; pharmaceutical information consultation, analysis and investigation and pharmaceutical market promotion; and research, development production, and sales of chemical raw material drugs and chemical preparations. The company was formerly known as Sunshine Lake Pharma Ltd. The company was established in 2001 and is based in Dongguan, China.

Employees
6299
Market
Hong Kong

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
9.43M1.64%373.37M
Other Institutional Investors
324.47M56.40%12.85B
Public Companies & Retail Investors
241.44M41.96%9.56B
Total
575.35M100.00%22.78B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Yichang HEC Research Co., Ltd.21.94%126,238,5004,999,045
Shenzhen Dongyangguang Industry Co., Ltd12.64%72,733,7522,880,257

FAQ

What Is the Sunshine Lake Pharma (6887) Stock Price Today?

The Sunshine Lake Pharma stock price today is 40.76 HKD.

What Stock Exchange Does Sunshine Lake Pharma Trade On?

Sunshine Lake Pharma is listed and trades on the Hong Kong Stock Exchange.

What Is the Stock Symbol for Sunshine Lake Pharma?

The stock symbol for Sunshine Lake Pharma is "6887."

What Is the Sunshine Lake Pharma Market Cap?

As of today, Sunshine Lake Pharma market cap is 23.45B HKD.

What Is Sunshine Lake Pharma's Earnings Per Share (TTM)?

The Sunshine Lake Pharma EPS (TTM) is -0.52.

From a Technical Analysis Perspective, Is 6887 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sunshine Lake Pharma Stock Split?

Sunshine Lake Pharma has split 1 times.

How Many Employees Does Sunshine Lake Pharma Have?

Sunshine Lake Pharma has 6299 employees.

What is the current trading status of Sunshine Lake Pharma (6887)?

As of Sep 29, 2026, Sunshine Lake Pharma (6887) is trading at a price of 40.76 HKD, with a previous close of 40.76 HKD. The stock has fluctuated within a day range of 39.34 HKD to 40.76 HKD, while its 52-week range spans from 15.01 HKD to 51.70 HKD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.